Status:
COMPLETED
Assisted Reproductive Technology (ART) Predictors Study
Lead Sponsor:
University of Oklahoma
Conditions:
Reproductive Aging
Eligibility:
FEMALE
18-44 years
Brief Summary
The goals of this research proposal are to further our understanding of the reproductive aging process in women and to improve our ability to clinically assess and model reproductive aging. Reproducti...
Detailed Description
To test our hypotheses, we will enroll 120 healthy women undergoing ART cycles at OU Physicians Reproductive Health. Patients undergoing an ART treatment cycle at the OU Physicians Reproductive Healt...
Eligibility Criteria
Inclusion
- Undergoing an ART treatment cycle
- Age range 18-44 years old
- NOTE: Must be willing to travel to Oklahoma City to participate. Need to have the transvaginal ultrasound and skin autofluorescence measurement at the OU Physicians Reproductive Health Clinic in Oklahoma City, Oklahoma
- NOTE: Study will not pay for ART/IVF treatment.
Exclusion
- Gynecological malignancy
- chemotherapy or radiation therapy treatment
- Autoimmune disease
- Prior ovarian surgery
- Ovarian pathology
Key Trial Info
Start Date :
September 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT00988611
Start Date
September 1 2009
End Date
December 1 2016
Last Update
March 20 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States, 73103